The Use of Serological Tests (I.F.A.T. and iELISA) for Evaluation of Specific Antibodies Level in Vaccinated and Nonvaccinated Animals Against Anthrax

Etleva Hamzaraj, Besa Ndoci, Pëllumb Muhedini, Agim Kruja


Various diseases, especially infectious ones, have caused untold harm to humanity in centuries. Among these, special attention should be paid to infectious diseases, especially anthrax, which reduces a lot the number of heads and livestock products. One of the most important tools to combat this infection are vaccinations. Today there are different kinds of vaccines against anthrax. The aim of this study was the use of IFA tests and iELISA to determine the efficacy of vaccines against anthrax. For the implementation of the IFA test bacterial emulsions prepared with bacterial strains of B. anthracis Stern 34F2 and Pasteur were used as antigens. As for determining the level of antibodies in the serum by iELISA was used Anthrax Protective antigen IgG ELISA kit. Sera of sheep and goat vaccinated with capsular and noncapsular vaccines were analyzed with both methods 21 days, 9 months and 12 months after vaccination. The results obtained show that sheep respond better to the vaccine than goat. The index of IgG anti-PA antibodies between vaccines, determined by ELISA, varies from 3.3 to 1.6 and 3.85 to 1.94, respectively, in the sera of animals vaccinated with noncapsular and capsular vaccines 21 days and 12 months after vaccination. For evaluation of vaccine immunogenicity, techniques of IgG anti-PA ELISA and indirect immunofluorescence (IFAT) can be used as alternative methods of control by the State Laboratory of Control of Veterinary Bioproducts.

DOI: 10.5901/ajis.2013.v2n9p642

Full Text: PDF

Licenza Creative Commons
This work is licensed under Creative Commons Attribution 3.0 License.

Academic Journal of Interdisciplinary Studies ISSN 2281 3993(Print) ISSN 2281-4612(Online)

Copyright © MCSER-Mediterranean Center of Social and Educational Research

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders..